CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Sands Stephen H. Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2026-01-02 | Milnes Alistair CHIEF OPERATING OFFICER | Grant or award | +50,000 | 143,377 | ||
| 2026-01-02 | Milnes Alistair CHIEF OPERATING OFFICER | Sale | −3,244 | $6.80 | $22K | 140,133 |
| 2026-01-02 | Milnes Alistair CHIEF OPERATING OFFICER | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2026-01-02 | Riva Alessandro Director | Grant or award | +7,380 | 19,880 | ||
| 2026-01-02 | Riva Alessandro Director | Grant or award · Stock Option (right to buy) | +14,761 | 14,761 | ||
| 2026-01-02 | Bourque Janice Director | Grant or award | +9,500 | 32,500 | ||
| 2026-01-02 | Bourque Janice Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2026-01-02 | Winter Gregory Paul Director | Grant or award | +9,500 | 196,427 | ||
| 2026-01-02 | Winter Gregory Paul Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2026-01-02 | Lee Kevin CHIEF EXECUTIVE OFFICER | Grant or award | +165,000 | 640,310 | ||
| 2026-01-02 | Lee Kevin CHIEF EXECUTIVE OFFICER | Sale | −10,325 | $6.80 | $70K | 629,985 |
| 2026-01-02 | Lee Kevin CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (right to buy) | +330,000 | 330,000 | ||
| 2026-01-02 | Skynner Michael CHIEF TECHNOLOGY OFFICER | Grant or award | +50,000 | 168,277 | ||
| 2026-01-02 | Skynner Michael CHIEF TECHNOLOGY OFFICER | Sale | −3,045 | $6.80 | $21K | 165,232 |
| 2026-01-02 | Skynner Michael CHIEF TECHNOLOGY OFFICER | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2026-01-02 | DANSEY ROGER D Director | Grant or award | +3,032 | 15,532 | ||
| 2026-01-02 | DANSEY ROGER D Director | Grant or award · Stock Option (right to buy) | +6,065 | 6,065 | ||
| 2026-01-02 | Gutierrez-Ramos Jose-Carlos Director | Grant or award | +9,500 | 32,500 | ||
| 2026-01-02 | Gutierrez-Ramos Jose-Carlos Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 |
Page 4 of 26 · 520 trades